Abeona Therapeutics (ABEO) Long-Term Debt Repayments (2026)
Abeona Therapeutics' Long-Term Debt Repayments was $3.33 million in Q2 2026, up 50.0% from the prior quarter.
Analysis
Abeona Therapeutics (ABEO) Long-Term Debt Repayments (2026) Analysis & Trends
For FY2012, Long-Term Debt Repayments at Abeona Therapeutics came in at $2.75 million, unchanged from FY2011.
- In earlier years, Long-Term Debt Repayments was $2.75 million in FY2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 1.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | Abeona Therapeutics | 251.79 Mn | -462.16 Mn | 7.20 Mn | 3.33 Mn |
API Access
Abeona Therapeutics Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ABEO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "ABEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ABEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();